Research progress on the application of CRISPR/Cas9 technology in breast cancer treatment

Yuxin Cai

DOI: https://doi.org/10.54254/2753-8818/20/20230776

2023-12-20

Abstract:Cancer is viewed as a severe health issue because it is one of the leading causes of mortality on a global scale. The most frequent type of cancer in women and one of the leading causes of mortality worldwide is breast cancer. Current treatments include surgical excision, hormone treatment, chemotherapy, radiotherapy, and targeted biological therapy. Although numerous treatments can relieve the symptoms or even cure the disease. Several genes are still waiting for discovery that affects the growing processes of tumors through a different pathway. Continuous effort is needed to develop more efficient and fewer side effect treatments. The genetic intervention has arisen as one of the most auspicious therapeutic alternatives in contemporary times. "CRISPR Cas9 has emerged as a compelling gene editing technology in the contemporary era, which is constructed by two main parts-the CRISPR-associated (Cas) endonuclease section and the CRISPR RNA (crRNA) section. CRISPR technology has been successfully utilized to establish gene-specific cell lines and animal models for studying gene function and their products in pathogenesis, as well as interactions between different genes. This paper summarizes the recent years of experiments using CRISPR/Cas9 technology to explore the mechanism of breast carcinogenesis, find appropriate therapeutic targets, and discuss the latent capacity of CRISPR/Cas9 technology in breast cancer treatment.